Gilad Almogy, Ultima Genomics CEO
Bay Area genomics startup emerges from stealth with $600M in the bank and promising a '$100 genome' test
When talking about genomics biotechs, financing rounds tend to be more on the modest side — an $18.5 million Series A round for one, …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
